Lenalidomide offers an effective alternative treatment for cutaneus lupus erythematosus, study suggests
Friday, December 7, 2012 - 15:00
in Health & Medicine
Although rare there are several treatments available for cutaneus lupus erythematosus (CLE). However other options are needed for people who do not respond to medication or relapse. A new study into the thalidomide derivative lenalidomide shows that treatment with lenalidomide is safe, with patients seeing an improvement in as little as two weeks.